Atogepant
Back to searchMolecule Structure
Scientific Name
Atogepant
Description of the Drug
Atogepant is an oral CGRP antagonist used for the preventative therapy of episodic migraine headaches.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB16098
http://www.drugbank.ca/drugs/DB16098
Brand Name(s)
Qulipta
Company Owner(s)
Abbvie Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Calcitonin gene-related peptide type 1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL3798 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4570348 |
| DrugBank | DB16098 |
| PubChem | 72163100 |
| BindingDB | 362044 |
| ChemicalBook | CB83368673 |
| Guide to Pharmacology | 9730 |
